<p>Representative case. Left: Reese-Ellsworth Group VB (IC D) left eye prior to treatment Right: Same eye following three OAC cycles consisting of carboplatin and topotecan. Note dramatic response of tumors following carboplatin/topotecan therapy.</p
Purpose: To evaluate the effect of adding topotecan to melphalan for the treatment of retinoblastoma...
Purpose: To evaluate the effect of adding topotecan to melphalan for the treatment of retinoblastoma...
INTRODUCTION: Intra-arterial chemotherapy is a novel therapeutic modality for retinoblastoma patient...
Purpose: Carboplatin administered systemically or periocularly can result in dramatic and prompt reg...
PURPOSE: Carboplatin administered systemically or periocularly can result in dramatic and prompt reg...
Carboplatin administered systemically or periocularly can result in dramatic and prompt regression o...
<p>Carboplatin +/− topotecan-containing ophthalmic artery chemosurgery: Characteristics of patients,...
<p>pt = patient, OAC = ophthalmic artery chemosurgery, %COAC = percentage of carboplatin-based OA...
Ophthalmic artery chemosurgery (OAC) for retinoblastoma was introduced by us 5 years ago for advance...
To report globe salvage rates, patient survival and adverse events of ophthalmic artery chemosurgery...
<div><p>Purpose</p><p>To report globe salvage rates, patient survival and adverse events of ophthalm...
BACKGROUND: Ophthalmic artery chemosurgery (OAC) for retinoblastoma was introduced by us 5 years ago...
We present our findings in a case of central retinal artery occlusion (CRAO) that developed in a pat...
Purpose: To evaluate the effect of adding topotecan to melphalan for the treatment of retinoblastoma...
Purpose: To evaluate the effect of adding topotecan to melphalan for the treatment of retinoblastoma...
Purpose: To evaluate the effect of adding topotecan to melphalan for the treatment of retinoblastoma...
Purpose: To evaluate the effect of adding topotecan to melphalan for the treatment of retinoblastoma...
INTRODUCTION: Intra-arterial chemotherapy is a novel therapeutic modality for retinoblastoma patient...
Purpose: Carboplatin administered systemically or periocularly can result in dramatic and prompt reg...
PURPOSE: Carboplatin administered systemically or periocularly can result in dramatic and prompt reg...
Carboplatin administered systemically or periocularly can result in dramatic and prompt regression o...
<p>Carboplatin +/− topotecan-containing ophthalmic artery chemosurgery: Characteristics of patients,...
<p>pt = patient, OAC = ophthalmic artery chemosurgery, %COAC = percentage of carboplatin-based OA...
Ophthalmic artery chemosurgery (OAC) for retinoblastoma was introduced by us 5 years ago for advance...
To report globe salvage rates, patient survival and adverse events of ophthalmic artery chemosurgery...
<div><p>Purpose</p><p>To report globe salvage rates, patient survival and adverse events of ophthalm...
BACKGROUND: Ophthalmic artery chemosurgery (OAC) for retinoblastoma was introduced by us 5 years ago...
We present our findings in a case of central retinal artery occlusion (CRAO) that developed in a pat...
Purpose: To evaluate the effect of adding topotecan to melphalan for the treatment of retinoblastoma...
Purpose: To evaluate the effect of adding topotecan to melphalan for the treatment of retinoblastoma...
Purpose: To evaluate the effect of adding topotecan to melphalan for the treatment of retinoblastoma...
Purpose: To evaluate the effect of adding topotecan to melphalan for the treatment of retinoblastoma...
INTRODUCTION: Intra-arterial chemotherapy is a novel therapeutic modality for retinoblastoma patient...